PFE vs VRT: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and Vertiv Holdings Co β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Pfizer Inc. Β· Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
VS
Vertiv Holdings Co Β· Industrials
$253.28
+8.2% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
PFE has more upside to fair value (+12.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric PFE VRT
Current Price $27.64 $253.28
Fair Value Estimate $30.94 $274.15
Upside to Fair Value +12.0% +8.2%
Market Cap $157.5B $97.5B
Forward P/E β€” β€”
EV / EBITDA 17.4x 38.8x
Price / Sales 2.5x 8.5x
Price / FCF 14.3x 33.3x
Revenue Growth YoY +2.6% +24.1%
Gross Margin 71.3% 37.5%
Operating Margin 25.1% 19.1%
Return on Equity 4.9% 42.1%
Dividend Yield 6.22% 0.1%
FCF Yield 6.97% 3.0%
Analyst Consensus Hold Strong Buy
Investment Thesis
PFE β€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
VRT β€” Vertiv Holdings Co
Vertiv Holdings Co is a global provider of critical digital infrastructure for data centers, communication networks, and industrial applications, spanning AC and DC power management, thermal cooling, integrated rack systems, and lifecycle services under brands including Liebert, NetSure, Geist, and Avocent, with roughly 34,000 employees and a global footprint across the Americas, Asia Pacific, an…
Accumulation Zones
Metric PFE VRT
Zone Low $23.21 $205.61
Zone High $26.30 $233.03
In Buy Zone? No No
← PFE Research    VRT Research β†’    All Research